Table 2 Results of subgroup analysis of herbal medicine use prevalence by region, study setting, and population type
Categories | Subgroups | Prevalence (95 % CI) | No of studies (%) | I2 |
|---|---|---|---|---|
Region | Mixed (Addis Ababa and Bati | 60% (56%, 64%) | 1 (2.78) | Â |
Oromia | 55 % (36%, 74%) | 9 (25.0) | 99.32% | |
Benshangul-Gumuz | 53 % (48%, 57%) | 1 (2.78) | - | |
Harari | 52 % (25%, 78%) | 3 (8.33) | - | |
SNNPR* | 33 % (30%, 36%) | 2 (5.56) | - | |
Amhara | 46 % (36%, 55%) | 16 (44.4) | 98.24% | |
Southwest Ethiopia | 24 % (21%, 27%) | 1 (2.78) | - | |
Addis Ababa | 19 % (1%, 50%) | 3 (8.33) | - | |
Setting | Community-based | 45 % (35%, 56%) | 16 (44.44) | 99.36% |
Institutional-based | 46 % (34%, 60%) | 20 (55.56) | 98.67% | |
Population type | Cancer patients | 72 % (65%, 78%) | 1 (2.78) | - |
Diabetic patients | 60 % (57%, 64%) | 2 (5.56) | . | |
General populations | 50 % (32%, 68%) | 8 (25.0) | 98.24% | |
HIV/TB coinfected patients | 53 % (48%, 57%) | 1 (2.78) | - | |
Pregnant women | 43 % (26%, 61%) | 12 (33.33) | 99.58% | |
Hypertensive patients | 43 % (40%, 47%) | 2 (5.56) | Â | |
Parents with children | 43 % (25%, 62%) | 4 (11.11) | - | |
Elderlies | 37 % (32%, 43%) | 1 (2.78) | - | |
HIV/AIDS | 37 % (8%, 71%) | 3 (8.33) | Â | |
Malaria suspects | 32 % (27%, 37%) | 1 (2.78) | - |